Ptrevas Pharmaceuticals Private Limited

Ptrevas Pharmaceuticals Private Limited - trading in Sangareddy, Telangana, India. FY 2026 financials & compliance.
CIN U24233TG2015PTC102512 Incorporated 31 December 2015 ROC Hyderabad HQ Sangareddy, Telangana, India
Active Private Limited Company trading
Data last updated
Revenue · FY 2019
₹9.31 Lakh
▼ 28% YoY
Net loss · FY 2019
₹2.75 Lakh
Net margin -29.5%
EBITDA · FY 2019
-₹2.63 Lakh
EBITDA margin -28.3%
Authorised capital
₹36 Lakh
Registered with MCA
Paid-up capital
₹36 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Ptrevas Pharmaceuticals Private Limited

Data last updated:

Ptrevas Pharmaceuticals Private Limited is a private limited company based in Sangareddy, Telangana, India. It operates in the retail trading segment of the trading and commerce sector. It was incorporated on 31 December 2015 and has been in existence for over 11 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2015PTC102512. Its GSTIN is 37AAICP4516H1ZB (Andhra Pradesh).

The company has an authorised share capital of ₹36 Lakh and a paid-up capital of ₹36 Lakh. It is led by directors including Aravind Gajjarapu (Managing Director) and Alekhya Mamidi.

Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Sangareddy, Telangana.

As per the financials filed for FY 2019, the company reported a revenue of ₹9.31 Lakh, a decline of 28% compared to the previous year. For the same year it recorded a net loss of ₹2.75 Lakh (net margin -29.5%) and EBITDA of -₹2.63 Lakh (EBITDA margin -28.3%).

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24233TG2015PTC102512
Registration Number 102512
Incorporation Date 31 December 2015
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2019
Date of Balance Sheet 31 March 2019
Compliance Status Active Compliant

Contact details

Ptrevas Pharmaceuticals Private Limited's registered office is in Sangareddy, Telangana. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No – 176 G.T.N. Colony Chitkul Villege Patancher, Vu Mandal, Sangareddy, Telangana, India – 502307
  • Industry
    Trading, Retail Trading, Retailers

To see the full contact details of Ptrevas Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Ptrevas Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Ptrevas Pharmaceuticals is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Ptrevas Pharmaceuticals Private Limited, buy the company report.

Financials of Ptrevas Pharmaceuticals Private Limited

FY 2019 filings available

Ptrevas Pharmaceuticals Private Limited reported revenue of ₹9.31 Lakh (down 28% YoY) for FY 2019.

Revenue · FY 2019
₹9.31 Lakh ▼ 28%
Net loss · FY 2019
₹2.75 Lakh margin -29.5%
EBITDA · FY 2019
-₹2.63 Lakh margin -28.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 28%
EBITDA CAGR growth
1 year
▼ 157%
3 years · compounded
▼ 37%

Revenue fell 28% in the latest year. EBITDA fell 157% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹2.63 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹2.75 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profitability
EBITDA Margin-28.3%
Net Profit Margin-29.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Ptrevas Pharmaceuticals Private Limited, buy the company report.

Board of directors of Ptrevas Pharmaceuticals Private Limited

Ptrevas Pharmaceuticals has 3 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Alekhya MamidiDirector04 Jun 20197 Years 5 MonthsCurrent
Lavanya KotipalliDirector04 Jun 20197 Years 5 MonthsCurrent
Aravind GajjarapuManaging Director31 Dec 201510 Years 10 MonthsCurrent

Auditor

Ptrevas Pharmaceuticals Private Limited is audited by MULAGADA PRATHAP RUDRUDU for the financial year 2017.

Auditor firmFinancial yearFirm registration number
MULAGADA PRATHAP RUDRUDUFY 2017006364S

Shareholding

The shareholding of Ptrevas Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Ptrevas Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Ptrevas Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Ptrevas Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
37AAICP4516H1ZBAndhra PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Ptrevas Pharmaceuticals Private Limited, buy the company report.

Recent activity

Ptrevas Pharmaceuticals Private Limited has 17 board changes on record since 2015: 3 appointments and 14 cessations. The latest: Alekhya Mamidi ceased to be Additional Director on 30 Sep 2019.

AGM
Ptrevas Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records.
Ceased
Alekhya Mamidi ceased to be Additional Director.
Ceased
Lavanya Kotipalli ceased to be Additional Director.
Appointed
Alekhya Mamidi was appointed as Director.
Ceased
Anasurya Gollapalli ceased to be Director.
Ceased
Kameswara Rao Talabhaktula ceased to be Director.
Appointed
Lavanya Kotipalli was appointed as Director.
Ceased
Raj Kumar Pottavathini ceased to be Director.
Ceased
Santosh Kumar Likhitapudi ceased to be Director.
Filing
Ptrevas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Hyderabad.
Ceased
Aravind Gajjarapu ceased to be Director.
Ceased
Veera Raghavulu Rayudu ceased to be Director.

8 earlier events are in the company report.

Frequently asked questions

Ptrevas Pharmaceuticals is an active private limited company based in Sangareddy, Telangana, India. The company works in retail trading, within the trading industry. It was incorporated on 31 December 2015 (11+ years old) and is registered under CIN U24233TG2015PTC102512.

Ptrevas Pharmaceuticals has 3 current directors:

The latest financial statements of Ptrevas Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from FY 2016 are in the company report.

The GSTIN of Ptrevas Pharmaceuticals is 37AAICP4516H1ZB, registered in Andhra Pradesh.

The CIN (Corporate Identification Number) of Ptrevas Pharmaceuticals is U24233TG2015PTC102512. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ptrevas Pharmaceuticals was incorporated on 31 December 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.

Alekhya Mamidi ceased to be Additional Director on 30 Sep 2019. Lavanya Kotipalli ceased to be Additional Director on 30 Sep 2019. Alekhya Mamidi was appointed as Director on 04 Jun 2019. Ptrevas Pharmaceuticals has 17 board changes on record in total.

The registered office of Ptrevas Pharmaceuticals is at Plot No – 176 G.T.N. Colony Chitkul Villege Patancher, Vu Mandal, Sangareddy, Telangana, India – 502307.

Ptrevas Pharmaceuticals operates in the trading industry, in the retail trading segment.

The compliance status of Ptrevas Pharmaceuticals is compliant as of 13 September 2026. The company is actively filing with the Registrar of Companies.